Galmed Pharmaceuticals Ltd. buy Needham & Company LLC
Start price
08.05.26
/
50%
€6.40
Target price
08.05.27
€99.77
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 08.05.27. The prediction end date can be changed by Needham___Company_LL at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | -1,11 % | 0,20 % |
| iShares Nasdaq 100 | -4,35 % | -3,25 % |
| iShares Nikkei 225® | -6,79 % | -7,72 % |
| iShares S&P 500 | -1,79 % | 0,99 % |
Comments by Needham___Company_LL for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (GMED) had its price target raised by Needham & Company LLC from $114.00 to $117.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Needham___Company_LL for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
25.02.26
25.02.26
€96.72
25.02.27
25.02.27
-
19.09.24
19.09.24
